Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and ...
When healthcare becomes simpler, reasonably priced, and genuinely accessible, India can finally bring advanced treatment to ...
Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for relapsed/refractory (R/R) follicular lymphoma (FL). Here, we report updated ...
In August, 2025, the US Food and Drug Administration (FDA) published a draft guidance on the assessment of overall survival in randomised cancer drug trials.1 In essence, the guidance states that ...
Scientists at St. Jude analyzed medulloblastoma data to better understand treatment needs, lowering treatment intensity and ...
Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Hello, and thank you for standing by. Welcome to Allogene ...
The adjusted r-squared is helpful for multiple regression and corrects for erroneous regression, giving you a more accurate ...
The next pandemic won’t just test our biology — it’ll test whether our AI and cybersecurity can survive the storm.
Cogent Biosciences, Inc. earns a Strong Buy rating due to positive phase 3 PEAK results for bezuclastinib + Sunitinib. Read ...
Neutering debates just got more complicated. An observational study of exceptionally long-lived Rottweilers reveals that male ...
The 2025 Nobel Prize in economic sciences was awarded to Joel Mokyr, Philippe Aghion, and Peter Howitt for explaining how innovation drives economic growth. Their work demonstrates that progress is ...